2Elsammak MY,Amin GM,Khalil GM,et al. Possible contribution of serum activin A and IGF -1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis [J].Clin Biochem, 2006,39(6) :623-629.
3Morali G,Shitrit AB,Eran M,et al. Expression of insulin - like growth factor -1 and insulin - like growth factor binding proteins during thioacetamide - induced liver cinhosis in rats[J]. Growth Horm IGF Res,2005, 15(5) :313-323.
4Sanz S, Pucilowska JB, Liu S, ct el. Expression of insulin - like growth factor Ⅰ by activated hepatic stellate cells reduces fibro genesis and enhances regeneration after liver injury[J]. Gut,2005,54( 1 ) : 134-141.
5Garcia - Fernandez M, Castilla - Cortazar I, Diaz - Sanchez M, et al. Antioxidant effects of insulin - like growth factor -1( IGF -1) in rats with advanced liver cirrhosis [ J ]. BMC Gastroentorol,2005 ,3 :5-7.
5Muller A, Machnik F, Zimmermann T, et al. Thioacetamide-induced cirrhosis-like liver lesions in rats-usefulness and relability of this animal model. Exp Pathol, 1988, 34:229-236.
6Higgins GM, Anderson RM. Experimental pathology of the liver.I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol, 1931,12:186-202.
7Tao RC, Yoshimura NN, Chinn IB, et al. Determination of intravenous non-protein energy and nitrogen requirements in growing rats. J Nutr, 1979,109:904-915.
8Caregaro L, Favaro A, Santonastaso P,et al. Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders.Clin Nutr,2001,20:251-257.
9Vyzantiadis T, Theodoridou S, Giouleme O, et al. Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis. Hepatogastroenterology,2003,50:814-816.
10Shaarawy M,Fikry MA,Massoud BA,et al. Insulin-like growth factor binding protein-3: a novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis. J Clin Endocrinol Metab,1998,83:3316-3319.
